Fulgent Genetics, Inc. (FLGT) › Operating IncomeFulgent Genetics, Inc. (FLGT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$990.0K2015: -$5.01M2016: $918.0K2017: -$3.48M2018: -$5.07M2019: -$428.0K2020: $290.16M2021: $675.95M2022: $178.53M2023: -$195.53M2024: -$73.92M2025: -$91.10M-$91.10M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$91.10M-23.2%2024-$73.92M+62.2%2023-$195.53M-209.5%2022$178.53M-73.6%2021$675.95M+133.0%2020$290.16M+67893.9%2019-$428.0K+91.6%2018-$5.07M-45.6%2017-$3.48M-479.3%2016$918.0K+118.3%2015-$5.01M-406.3%2014-$990.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share